Cervical cancer is primarily caused by the Human Papillomavirus (HPV). Because this link is well-established, medical science has developed highly effective vaccines that can prevent the onset of the disease. In addition to regular screening, vaccination is considered the most powerful tool in the global effort to eliminate cervical cancer.
Types of Vaccines Available
There are several internationally recognized vaccines used to protect against HPV. These include Gardasil and Cervarix, which have been used globally for many years. Additionally, a new indigenous vaccine developed in India, called CERVAVAC, has recently become available, making protection more accessible to a wider population.
Who Should Get the Vaccine?
The effectiveness of the vaccine is highest when administered before an individual is exposed to the virus.
-
Ideal Age: The most recommended age for vaccination is for girls between 9 and 15 years old.
-
Extended Age Group: While early vaccination is ideal, the vaccine can still be considered for women up to the age of 45, following a consultation with a healthcare professional.
Dosage Schedule
The number of doses required depends on the age at which the first dose is administered:
-
Below 15 Years: Two doses are typically required.
-
Above 15 Years: A three-dose schedule is generally recommended to ensure full protection.
Comprehensive Cancer Protection
While it is primarily known as the “cervical cancer vaccine,” its benefits extend much further. By preventing HPV infection, the vaccine also provides significant protection against several other types of cancer that affect both women and men, including:
-
Vaginal and vulval cancers
-
Penile cancer in men
-
Oropharyngeal cancer (cancers of the throat and mouth)
-
Other related malignancies
By prioritizing vaccination for young girls and following the recommended screening guidelines for adults, we can significantly reduce the incidence of these cancers and work toward a future where cervical cancer is a disease of the past.
